Acellular tissue matrices made from α-1,3-galactose-deficient tissue
US8802920B2 · kind B2 · utility
6Cited by
27References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2012 |
| Grant date | Aug 12, 2014 |
| Priority date | — |
| Expiry date | Nov 16, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/6854
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides acellular tissue matrices made from collagen-containing tissues of animals genetically modified so as to be deficient in the galactose 1,3-galactose epitope and methods of making and using such acellular tissue matrices.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.